United Kingdom

People: Omeros Corp (OMER.OQ)

OMER.OQ on NASDAQ Stock Exchange Global Market

9:00pm BST
Change (% chg)

$-0.41 (-2.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Demopulos, Gregory 

Dr. Gregory A. Demopulos, M.D., is Chairman of the Board, President, Chief Executive Officer of Omeros Corp. He also served as our chief financial officer and treasurer from January 2009 to October 2013 in an interim capacity, and served as our chief medical officer from June 1994 to March 2010. Prior to founding Omeros, Dr. Demopulos completed his residency in orthopedic surgery at Stanford University and his fellowship training in hand and microvascular surgery at Duke University. Dr. Demopulos currently serves on the board of trustees of the Smead Funds Trust, an open-end mutual fund company registered under the Investment Company Act of 1940. His non-profit service includes the Seattle Community Development Round Table and the Northwest NeuroNeighborhood board of directors. Dr. Demopulos received his M.D. from the Stanford University School of Medicine and his B.S. from Stanford University

Basic Compensation

Total Annual Compensation, USD 1,649,770
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,885,520
Fiscal Year Total, USD 4,535,280

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 142,001 2,365,120.00
Name Fiscal Year Total

Gregory Demopulos


Michael Jacobsen


Marcia Kelbon


Daniel Kirby


Justin McCue


Thomas Cable

As Of  31 Dec 2017